Direct Oral Anticoagulants Versus Vitamin K Antagonist (Warfarin) For Stroke Prevention In Frail Patients With Atrial Fibrillation: A Meta-Analysis

Rupak Desaia Independent Outcomes Researcher, Atlanta, Georgia

, MBBS,

Aobo Lib Department of Internal Medicine, Beijing Anzhen Hospital, Beijing, China

, MD,

Avilash Mondalc Internal Medicine, Nazareth Hospital Philadelphia, Philadelphia, Pennsylvania

, MD,

Priya Shenwaid Department of Surgery, NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York

, MD,

Bhavyasri Merugue Department of Medicine, Vydehi Institute of Medical Sciences and Research Centre, Karnataka, India

, MBBS,

Frailyn J. Nunez Guzmanf Department of Internal Medicine, St. Barnabas Hospital, Bronx, New York

, MD &

Akhil Jaing Department of Internal Medicine, Mercy Catholic Medical Center, Darby, Pennsylvania

https://orcid.org/0000-0001-7298-4246

, MD

show all

"Direct Oral Anticoagulants Versus Vitamin K Antagonist (Warfarin) For Stroke Prevention In Frail Patients With Atrial Fibrillation: A Meta-Analysis." Baylor University Medical Center Proceedings, 36(2), pp. 274–275

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Direct Oral Anticoagulants Versus Vitamin K Antagonist (Warfarin) For Stroke Prevention In Frail Patients With Atrial Fibrillation: A Meta-Analysis

Information for

Open access

Opportunities

Help and information

Direct Oral Anticoagulants Versus Vitamin K Antagonist (Warfarin) For Stroke Prevention In Frail Patients With Atrial Fibrillation: A Meta-Analysis

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature